Incyte
INCY
#980
Rank
$24.38 B
Marketcap
$119.65
Share price
1.39%
Change (1 day)
12.90%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2023 (TTM): $1.90

According to Incyte's latest financial reports the company's current EPS (TTM) is $2.10. In 2022 the company made an earnings per share (EPS) of $1.54 a decrease over its 2021 EPS that were of $4.29.

EPS history for Incyte from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.9023.38%
2022$1.54-64.1%
2021$4.29-408.63%
2020-$1.39-166.83%
2019$2.08300%
2018$0.52-133.33%
2017-$1.56-378.57%
2016$0.562700%
2015$0.02000-106.67%
2014-$0.30-44.44%
2013-$0.5450%
2012-$0.36-75.68%
2011-$1.48469.23%
2010-$0.26-87.38%
2009-$2.064.04%
2008-$1.9892.23%
2007-$1.0315.73%
2006-$0.89-27.64%
2005-$1.23-44.34%
2004-$2.21-5.56%
2003-$2.3415.27%
2002-$2.03-26.71%
2001-$2.77483.16%
2000-$0.48-1.04%
1999-$0.48-838.46%
1998$0.06500-59.38%
1997$0.16-194.12%
1996-$0.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
$5.25 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$30.87 1,369.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$16.22 672.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$10.01 376.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-$0.11-105.24%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-$0.58-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-$0.84-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-$0.22-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA